Erectile Dysfunction in the Cancer Patient

Melman A. , Gingell J.C. The epidemiology and pathophysiology of erectile dysfunction. J Urol. 1999; 161: 5–11.

Lue T.F. Physiology of erection and pathophysiology of impotence. In: Walsh P.C. , Retik A.B. , Stamey T.A. , eds. Campbell's Urology. 6th ed. Philadelphia, Pa: W.B. Saunders Co; 1992: 709–715.

Walsh P.C. Anatomic radical prostatectomy: evolution of the surgical technique. J Urol. 1998; 160: 2418–2424.

Donohue J.P. , Foster R.S. , Rowland R.G. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol. 1990; 144: 287–291.

Goldstein I. , Feldman M.I. , Deckers P.J. Radiation-associated impotence: a clinical study of its mechanism. JAMA. 1984; 251: 903–910.

Flanigan R.C. , Patterson J. , Mendiondo O.A. Complications associated with preoperative radiation therapy and iodine-125 brachytherapy for local prostatic carcinoma. Urology. 1983; 22: 123–126.

Wein A.J. , Van Arsdalen K.N. Drug-induced male sexual dysfunction. Urol Clin North Am. 1988; 15: 23–31.

Grimm R.H. , Grandits G. , Svendsen K. Sexual problems and antihypertensive drug treatment: results of the Treatment of Mild Hypertension Study (TOMHS). J Urol. 1996; 155: 469A.

Mannino D.M. , Klevens R.M. , Flanders W.D. Cigarette smoking: an independent risk factor for impotence? Am J Epidemiol. 1994; 140: 1003–1008.

Boolell M. , Allen M.J. , Ballard S.A. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res. 1996; 8: 47–52.

Kloner R.A. Viagra: what every physician should know. Ear Nose Throat J. 1998; 77: 783–786.

Williams G. , Abbou C.C. , Amar E.T. Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction: MUSE Study Group. Br J Urol. 1998; 81: 889–894.

Fulgham P.F. , Cochran J.S. , Denman J.L. Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting. J Urol. 1998; 160: 2041–2046.

Broderick G.A. Intracavernous pharmacotherapy: treatment for the aging erectile response. Urol Clin North Am. 1996; 23: 111–126.

Ismail M. , Abbott L. , Hirsch I.H. Experience with intracavernous PGE-1 in the treatment of erectile dysfunction; dose considerations and efficacy. Int J Impot Res. 1997; 9: 39–42.

Montorsi F. , Guazzoni G. , Strambi L.F. Recovery of spontaneous erectile function after nerve-sparing radical prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol. 1997; 158: 1408–1410.